351
Active Trials
100
Phase 1
112
Phase 2
172
Phase 3
15
Therapeutic Areas
Portfolio Concentration: 80% of active trials in Oncology
Oncology
280 active / 422 total
NSCLC
51 active
24 Ph3
72 total since 2015
Breast Cancer
28 active
18 Ph3
40 total since 2015
Solid Tumor (Advanced)
25 active
9 Ph3
44 total since 2015
Prostate Cancer
15 active
6 Ph3
23 total since 2015
Gastric Cancer
14 active
3 Ph3
14 total since 2015
Ovarian Cancer
12 active
4 Ph3
27 total since 2015
Non-Hodgkin Lymphoma
12 active
2 Ph3
21 total since 2015
Hepatocellular Carcinoma
12 active
7 Ph3
12 total since 2015
Esophageal Cancer
10 active
3 Ph3
13 total since 2015
SCLC
9 active
6 Ph3
19 total since 2015
Bladder Cancer
9 active
6 Ph3
10 total since 2015
Pancreatic Cancer
8 active
14 total since 2015
Colorectal Cancer
8 active
11 total since 2015
Cholangiocarcinoma
8 active
4 Ph3
10 total since 2015
Endometrial Cancer
8 active
3 Ph3
8 total since 2015
Lung Cancer (General)
6 active
1 Ph3
11 total since 2015
ALL
6 active
2 Ph3
10 total since 2015
Head and Neck Cancer
6 active
2 Ph3
10 total since 2015
CLL
5 active
2 Ph3
9 total since 2015
Cervical Cancer
4 active
1 Ph3
6 total since 2015
Multiple Myeloma
4 active
1 Ph3
6 total since 2015
Renal Cell Carcinoma
4 active
2 Ph3
4 total since 2015
HER2- Breast Cancer
3 active
2 Ph3
5 total since 2015
Triple Negative Breast Cancer
3 active
4 total since 2015
Melanoma
2 active
4 total since 2015
Hodgkin Lymphoma
2 active
3 total since 2015
Squamous Cell Carcinoma
1 active
2 total since 2015
MDS
1 active
2 total since 2015
Mesothelioma
1 active
1 Ph3
1 total since 2015
Merkel Cell Carcinoma
1 active
1 total since 2015
Glioblastoma
1 active
1 total since 2015
Brain Tumor
1 active
1 total since 2015
Hematologic Malignancies
0 active
2 total since 2015
AML
0 active
2 total since 2015
Immunology
60 active / 158 total
Rheumatoid Arthritis
27 active
15 Ph3
54 total since 2015
Ankylosing Spondylitis
21 active
14 Ph3
62 total since 2015
Lupus
9 active
5 Ph3
18 total since 2015
Crohn's Disease
3 active
8 total since 2015
Ulcerative Colitis
0 active
8 total since 2015
IBD
0 active
3 total since 2015
Psoriasis
0 active
3 total since 2015
Atopic Dermatitis
0 active
2 total since 2015
Respiratory
26 active / 143 total
Cardiovascular
18 active / 110 total
Myocardial Infarction
13 active
5 Ph3
50 total since 2015
Heart Failure
3 active
2 Ph3
29 total since 2015
Hypertension
1 active
1 Ph3
14 total since 2015
Atrial Fibrillation
1 active
1 Ph3
7 total since 2015
Coronary Artery Disease
0 active
8 total since 2015
Thrombosis
0 active
1 total since 2015
Stroke
0 active
1 total since 2015
Urology
9 active / 39 total
Renal
9 active / 31 total
Metabolic
7 active / 79 total
Obesity
4 active
6 total since 2015
Type 2 Diabetes
1 active
35 total since 2015
Dyslipidemia
1 active
11 total since 2015
Diabetes (General)
1 active
8 total since 2015
NASH/NAFLD
0 active
13 total since 2015
Type 1 Diabetes
0 active
4 total since 2015
Diabetic Complications
0 active
2 total since 2015
Infectious Disease
4 active / 31 total
Rare Disease
2 active / 21 total
CNS
1 active / 10 total
Hepatology
1 active / 5 total
Endocrine
1 active / 1 total
Musculoskeletal
0 active / 4 total
Pain
0 active / 4 total
Gastrointestinal
0 active / 2 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)